T9M-20635-95792
2 vaccinations
1 coded response
16 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 224 / VA
- Registered
- 2023-03-11
- Relationship
- Child or adolescent in my care
- Guardian
- 6YX-32589-85942
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-02-27
Dose 1 — Moderna
-
2023-03-11
Registered in v-safe
- 2023-03-11
- 2023-03-13
- 2023-03-20
- 2023-03-27
-
2023-04-03
Dose 2 — Moderna
-
2023-04-03
Health check-in — day 0, dose 2, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
-
2023-04-04
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2023-04-05
- 2023-04-06
- 2023-04-07
- 2023-04-08
- 2023-04-10
-
2023-04-19
Survey response — day 14, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: GoodMedDRA releases: 2024-11
- 2023-04-24
- 2023-05-01
- 2023-05-08
- 2023-05-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-02-27 | Moderna | No |
| 2 | 2023-04-03 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release